Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
US Market
Holding ZNTL?
Track your performance easily

Zentalis Pharmaceuticals (ZNTL) Financial Statements

251 Followers

Zentalis Pharmaceuticals Financial Overview

Zentalis Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.356; its P/E ratio is -1.18; Zentalis Pharmaceuticals is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 40.56M----
Gross Profit$ 40.56M$ 900.00K---
EBIT$ -24.77M$ -67.92M$ -55.51M$ -99.47M$ -60.84M
EBITDA$ -24.44M$ -67.58M$ -57.23M$ -102.34M$ -63.74M
Net Income Common Stockholders$ 10.07M$ -60.92M$ -62.74M$ -112.53M$ -63.22M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 37.62M$ 482.92M$ 516.64M$ 552.99M$ 392.52M
Total Assets$ 557.48M$ 551.69M$ 585.72M$ 621.44M$ 489.34M
Total Debt$ 42.62M$ 43.15M$ 43.27M$ 44.03M$ 44.77M
Net Debt$ 5.00M$ -439.77M$ -473.37M$ -508.96M$ -347.75M
Total Liabilities$ 98.71M$ 114.30M$ 103.82M$ 98.16M$ 103.68M
Stockholders Equity$ 458.77M$ 437.28M$ 481.77M$ 523.14M$ 385.49M
Cash Flow-
Free Cash Flow$ -52.01M$ -40.77M$ -38.76M$ -79.59M$ -49.24M
Operating Cash Flow$ -51.97M$ -40.60M$ -38.66M$ -79.28M$ -49.24M
Investing Cash Flow$ 61.55M$ -42.06M$ -117.45M$ 72.93M$ 42.12M
Financing Cash Flow$ 7.00K-$ 309.00K$ 236.62M$ 373.00K
Currency in USD

Zentalis Pharmaceuticals Earnings and Revenue History

Zentalis Pharmaceuticals Debt to Assets

Zentalis Pharmaceuticals Cash Flow

Zentalis Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis